- Research article
- Open Access
New lanostane-type triterpene acids from wolfiporia extensa
Chemistry Central Journalvolume 6, Article number: 39 (2012)
Dried sclerotia of Wolfiporia extensa (Polyporaceae) is used to invigorate the spleen and to tranquilize the mind in Chinese herbal medicine. Lanostane-type triterpene acids were regard as major secondary metabolites from dried sclerotia of W. extensa.
Three new lanostane-type triterpene acids, 3-epi-benzoyloxyl-dehydrotumulosic acid (1), 3-epi-(3′-O-methyl malonyloxy)-dehydrotumulosic acid (2) and 3-epi-(3′-hydroxy-3′-methylglutaryloxyl)-dehydrotumulosic acid (3), were isolated from the sclerotia of W. extensa, together with 3 known lanostane derivatives (4–6). Their structures were elucidated on the basis of spectroscopic analysis, including 1D and 2D-NMR techniques.
Six lanostane derivatives including three new triterpene acids and three known compounds were reported from the sclerotia of W. extensa in this paper.
Dried sclerotia of Wolfiporia extensa (Polyporaceae), well known as ‘Fu-Ling’ in China, is used to invigorate the spleen and to tranquilize the mind in Chinese herb medicine . In combination with some other herbs, it shows activities as diuretic, sedative and analgesic . Lanostane-type triterpenes were reported as major secondary metabolites, which are characterized with hydroxyl groups at C-16 position, and with a C-21 carboxylic acid group. A number of lanostane-type triterpene acids have been reported from dried sclerotia of W. extensa, in which some lanostane derivatives showed activities in the anti-tumor, anti-inflammatory and anti-oxidant activities [3–9]. As part of our continuing research on chemical constituents from Traditional Chinese Medicine (TCM) [10–12], three new lanostane-type triterpene acids, 3-epi-benzoyloxyl-dehydrotumulosic acid (1), 3-epi-(3′-O-methyl malonyloxy)-dehydrotumulosic acid (2) and 3-epi-(3′-hydroxy-3′-methylglutaryloxyl)-dehydrotumulosic acid (3) were isolated from the dried sclerotia of W. extensa, together with three known lanostane derivatives (4 6) (Figure 1). Here we report the structure elucidation of the new compounds as follows.
Results and discussion
The dried sclerotia of W. extensa were extracted with 95% ethanol as described in Experimental part. The ethanolic extract was concentrated under reduced pressure to small volume and the solution was fractionated with a HPD-826 macroporous adsorptive resin column eluting with H2O and 90% EtOH. The 90% EtOH fraction was concentrated and repeatedly fractionated on reverse-phase ODS, and on silica gel column to obtain six lanostane-type triterpene acids (1 6). Of them, 4 6 were identified as known compounds, dehydropachymic acid (4) , dehydrotumulosic acid (5)  and 3-epi-dehydrotumulosic acid (6)  (Figure 1) by spectroscopic methods and comparison with reported data. Compounds 1 3 were identified as new compounds based on a detailed analysis of NMR as described below (Tables 1 and 2).
Compound 1 was obtained as a colourless crystal in CH3OH. The molecular formula was determined as C38H52O5 from its positive HRESI-MS ([M + H]+m/z 589.3864) and 13 C-NMR spectrum. The UV spectrum showed absorption at 234 nm, indicating the presence of a Δ7,9(11) diene moiety, which was further supported by an absorption band at 1641 cm-1 in the IR spectrum. Strong IR absorption at 3400 and 1710 cm-1 indicated the carboxyl group in 1. The 1 H-NMR spectrum of 1 showed signals from two secondary methyls (δ 0.97 and 0.99, each 3 H, d, J = 6.8 Hz), five tertiary methyls (δ 0.92, 0.95, 1.04, 1.06 and 1.48, each 3 H, s), two oxygen-bearing methylenes δ 4.52 (1 H, t, J = 6.8 Hz) and δ 5.09 (1 H, br s)], one terminal methylene group at δ 4.84 (1 H, s) and 4.97 (1 H, s), two olefinic methylenes at δ 5.39 (1 H, d, J = 5.6 Hz) and δ 5.64 (1 H, br s)], together with signals from typical benzoyl group δ 8.18 (2 H, d, J = 7.2 Hz), 7.35 (2 H, d, J = 7.6 Hz), 7.46(1 H, t, J = 7.4 Hz)] (Table 1). 13 C-NMR and DEPT spectra of 1 showed signals from 38 carbons, including one carboxyl carbon δ 178.6 (C-21)], two carbons from terminal methylene group δ 107.0 (C-31) and 156.1 (C-24)], four olefinic carbons δ 116.7 (C-11), 120.8 (C-7), 142.9 (C-8) and 146.0 (C-9)], two oxygenated methylenes δ 79.0 (C-3) and 76.4 (C-16)], seven methyl carbons δ 17.6 (C-18), 21.9 (C-27), 22.0 (C-26), 22.4 (C-29), 22.7 (C-19), 26.6 (C-30) and 28.1 (C-28)], signals from benzoyl group δ 165.9 (C-7′), 133.2 (C-4′), 131.4 (C-1′), 129.8 (C-2′, 6′), and 128.9 (C-3′, 5′)], and signals from other fifteen carbons (see Table 2). The aforementioned NMR features were similar to those of 3-epi-dehydrotumulosic acid (6), except for the existence of an additional set of signals arising from the benzoyl group in 1.
The downfield shift at C-3 (δ 79.0) in 1, from (δ 75.1) in 6, suggested that the additional benzoyl group was linked to C-3 position of dehydrotumulosic acid moiety. It was further confirmed by the HMBC experiment which showed correlation between H-3 (δ 5.09) with the signal from C-7′ (δ 165.9) of the benzoyl groups.
The relative configuration was established by 1 H-NMR and the NOESY experiment, in which the H-3 appeared as a broad singlet, the NOESY correlations of H-3β at (δ 5.09, 1 H, br s) with Me-29β at (δ 0.95, 3 H, s) revealed the benzoyl linked the α position of C-3 in compound 1. On the basis of the above evidence, the structure of 1 was elucidated as 3α-benzoyl-16α-dihydroxyl-lanost-7, 9(11), 24(31)-trien-21-oic acid, named as 3-epi-benzoyloxyl-dehydrotumulosic acid.
Compound 2 was obtained as a colourless needle in CH3OH. Careful comparison of 13 C-NMR spectra of 1 and 2 indicate that both have a similar lanostane skeleton with different substitution group (details in Table 2). Unlike compound 1 with a benzoyl group, compound 2 showed signals from a malonyl group δ 41.9 (−CH2-), 166.4 (−COO-) and 167.6 (−COO-)] and a methoxyl group δ 52.2 (−OCH3)]. HMBC experiment showed correlations between methoxyl proton (δ 3.63) with 3′-C (δ 166.4, from malonyl group) indicated the methyl malonate group . The HMBC experiment of 2 revealed the correlation between H-3 (δ 4.86) and C-1′ (δ 167.6), indicated the 3-substitution. Thus, compound 2 was established as 3-α-methyl-malonyl-16α-dihydroxy-lanost-7, 9(11), 24(31)-trien-21-oic acid, named as 3-epi-(3′-O-methyl malonyloxy)-dehydrotumulosic acid.
The 13 C-NMR spectra of 3 showed signals from a lanostane skeleton similar to those of 1 and 2 (Table 2), except with different substitution groups. Except signals from lanostane skeleton in compound 31 H-NMR showed signals at δ 3.12 (1 H, d, J = 15.2 Hz, H-2′), 3.16 (1 H, d, J = 15.2 Hz, H-2′), 3.02 (1 H, d, J = 14.4 Hz, H-4′), 3.08 (1 H, d, J = 14.4 Hz, H-4′) and 1.71 (3 H, s, -CH3)] along with 13 C-NMR showed signals δ 171.4 (C-1′), 46.3 (C-2′), 69.9 (C-3′), 46.4 (C-4′), 174.6 (C-5′), and 28.4 (−CH3)]. Those signals were assigned to 3-hydroxy-3-methylglutaryl group based on HMQC and HMBC spectra data. It was further confirmed from ESI-MS experiment, which showed fragment ions at m/z 525.4 [M-H-102 (CH (CH3) (OH)-CH2-COOH)]-. The HMBC correlations of H-3 (δ 4.94 br s) with C-1′ (δ 171.4) confirmed that the 3-hydroxy-3-methylglutaryloxyl group was at C-3 in 3 (Figure 1). The compound 3 is levorotatory. The R-configurations of C(3′) in 3 was deduced by comparing of the compound 3 specific rotation features with those of (+)-3-epi-dehydrotumulosic acid, and (3′ S)-(+)-3-hydroxy-3-methylglutaric acid, which are dextrorotatory [8, 13]. These evidences indicated R-configuration of C (3′) in compound 3. As stated above, the structure of 3 was indicated as 3-α-(3′-hydroxy-3′-methylglutaryloxy)-16α-dihydroxy-lanost-7, 9(11), 24(31)-trien-21-oic acid, named as 3-epi-(3′-hydroxy-3′-methylglutaryloxyl)-dehydrotumulosic acid.
General experimental procedures
Optical rotations were measured on a P-1020 Polarimeter (JASCO, Tokyo, Japan). UV spectra were obtained on a UV 210A Shimadzu spectrometer. IR spectra were recorded on an FT-IR spectrometer (Nicolet iS10, Thermo Scientifi, USA) with KBr pellets. 1 H- and 13 C-NMR spectrum was recorded in pyridine-d5 with Bruker AM-400, DRX-500 and VARIAN INOVA-600 spectrometers operating at 400, 500 and 600 MHz for 1 H-NMR experiments, and 125 and 150 MHz for 13 C-NMR experiment, respectively. Coupling constants are expressed in Hertz (Hz) and chemical shifts are given on a δ (ppm) scale with tetramethylsilane as internal standard. Negative ion ESI-MS and HRESI-MS were recorded on an AutoSpec 3000 spectrometer (VG, Manchester, UK). Column chromatography separations were performed using HPD-826 (Cangzhou Bon Adsorber Technology Co., Cangzhou, China), Chromatorex ODS (Fuji Silysia Chemical Co., Greenville, USA) and Silica gel (Qingdao Haiyang Chemical Co., Qingdao, China) as adsorbants. TLC was carried on silica gel G precoated plates (Qingdao Haiyang Chemical Co., Qingdao, China). The TLC plate was monitored by spraying with 10% H2SO4 solution in ethanol followed by heating.
The dried sclerotia of W. extensa were collected from Hebei Guang Ming Prepared Medicinal Herbs Co., Ltd, China and identified by Prof. Yu-Ting Cheng (Beijing University of Chinese Medicines). An authentic sample was kept in School of Chinese Pharmacy, Beijing University of Chinese Medicines.
Extraction and isolation
The dried sclerotia of W. extensa (17.5 kg) were powdered and extracted with exhaustively 95% EtOH under reflux. The EtOH extract was concentrated to the small volume (3 L), and applied on a HPD-826 macroporous adsorptive resin (15 Kg, 18 cm × 150 cm), eluting with H2O (60 L) and 90% EtOH (80 L). The 90% EtOH fraction was concentrated under reduced pressure, and the residue (60 g) was subjected to column chromatography (CC) on silica gel eluted with CHCl3/CH3OH (4:1 to 1:1, 5 L) to obtain eight fractions (Fr 1–Fr 8). Fr 1, was further fractionated on silica gel eluted with cyclohexane/CHCl3 (8:1 and 4:1, each 1 L), and ODS eluted with a step gradient of H2O/MeOH (1:0 → 0:1), and PTLC (Cyclohexane/CHCl3/HOAc, 3:1:0.1) to give 1 (20 mg), 2 (10 mg) and 4 (10 mg). Fraction 2 was fractionated repeatedly on Silica gel (CHCl3/EtOAc, 8:1) and ODS (CH3OH/H2O, 75:25 → 85:15), eluted with CHCl3/CH3OH (50:1), to obtain 5 (20 mg) and 6 (10 mg) from Fr 2. Fr 3 was subjected to CC on silica gel (CHCl3/EtOAc, 4:1), and preparative TLC on silica gel (CHCl3/EtOAc/HOAc, 1:1:0.1) to obtain 3 (20 mg).
3-epi-benzoyloxyl-dehydrotumulosic acid (1)
Colourless needles; 1 H-NMR (in pyridine-d5): see Table 1. 13 C-NMR (in pyridine-d5): see Table 2. IR (KBr) cm-1: 3400, 2928, 1710, 1641, 1279, 1175, 895, 800. UV λMeOH max nm (logϵ): 234 (4.32). HRESI-MS (m/z): 589.3864 [M + H]+, calcd for C38H53O5, 589.3893. ESI-MS (m/z) (rel. int.): 587.3 [M - 1]- (100), 417.0 (23), 338.9 (4), 208.8 (13).
3-epi-(3′-O-methyl malonyloxy)-dehydrotumulosic acid (2)
Colourless needles; 1 H-NMR (in pyridine-d5): see Table 1. 13 C-NMR (in pyridine-d5): see Table 2. IR (KBr) cm-1: 3416, 2960, 1736, 1707, 1641, 1254, 1152, 891, 800. UV λMeOH max nm (logϵ): 243 (4.16). HRESI-MS (m/z): 607.3605 [M + Na]+, calcd for C35H52O7Na, 607.3611.
3-epi-(3′ -hydroxy-3′-methylglutaryloxyl)-dehydrotumulosic acid (3)
Colourless needles; [α] = − 7.6 (c = 0.1705, pyridine); 1 H-NMR (in pyridine-d5): see Table 1. 13 C-NMR (in pyridine-d5): see Table 2. IR (KBr) cm-1: 3389, 2962, 1707, 1642, 1205, 1176, 891, 802, 780, 770. UV λMeOH max nm (logϵ): 244 (4.13); HRESI-MS (m/z): 651.3880 [M + Na]+, calcd for C37H56O8Na, 651.3873. ESI-MS (m/z) (rel. int.): 627.5 [M - 1]- (100), 525.4 (5).
The Pharmacopoeia Commission of P.R.C: Pharmacopoeia of People’s Republic of China. 2010, Chemical Industry Press, Beijing, 224-
Giner-Larza EM, Mánez S, Giner-Pons RM, Carmen RM, Ríos JL: On the anti-inflammatory and anti-phospholipase A2 activity of extracts from lanostane-rich species. J Ethnopharmacology. 2000, 73: 61-69. 10.1016/S0378-8741(00)00276-2.
Ukiya M, Akihisa T: Inhibition of tumor-promoting effects by poricoic acids G and H and other lanostane-type triterpenes and cytotoxic cctivity of poricoic acids A and G fromPoria cocos. J Nat Prod. 2002, 65: 462-465. 10.1021/np0103721.
Akihisa T, Nakamura Y, Tokuda H, Uchiyama E, Suzuki T, Kimura Y, Uchikura K, Nishino H: Triterpene acids fromPoria cocosand their anti-tumor-promoting effects. J Nat Prod. 2007, 70: 948-953. 10.1021/np0780001.
Akihisa T, Uchiyama E, Kikuchi T, Tokuda H, Suzuki T, Kimura Y: Anti-tumor-promoting effects of 25-methoxyporicoic acid A and other triterpene acids fromPoria cocos. J Nat Prod. 2009, 72: 1786-1792. 10.1021/np9003239.
Nukaya H, Yamashiro H, Fukazawa H, Ishida H, Tsuji K: Isolation of inhibitors of TPA-induced mouse ear edema from hoelen. Poria cocos. Chem Pharm Bull. 1996, 44: 847-
Yasukawa K, Kaminaga T, Kitanaka S, Tai T, Nunoura Y, Natori S, Takido M: 3β-p-Hydroxybenzoyldehydrotumulosic acid fromPoria cocos, and its anti-inflammatory effect. Phytochemistry. 1998, 48: 1357-1360. 10.1016/S0031-9422(97)01063-7.
Kamo T, Asanoma M, Shibata H, Hirota M: Anti-inflammatory lanostane-type triterpene acids fromPiptoporus betulinus. J Nat Prod. 2003, 66: 1104-1106. 10.1021/np0300479.
Zhou L, Zhang YC, Gapter LA, Ling H, Agarwal R, Ng K: Cytotoxic and anti-oxidant activities of lanostane-type triterpenes isolated fromPoria cocos. Chem Pharm Bull. 2008, 56: 1459-1462. 10.1248/cpb.56.1459.
She GM, Wang D, Zeng SF, Yang CR, Zhang YJ: New Phenylethanoid glycosides and sugar esters from Ku-Ding-Cha, a herbal tea produced fromLigustrum purpurascens. J Food Sci. 2008, 73: C476-C481. 10.1111/j.1750-3841.2008.00830.x.
She GM, Xu C, Liu B, Shi RB: Polyphenolic acids from mint (the aerial ofMentha haplocalyxBriq.) with DPPH Radical Scavenging Activity. J Food Sci. 2010, 75: C359-C362. 10.1111/j.1750-3841.2010.01603.x.
She GM, Xu C, Liu B, Shi RB: Two new monoterpenes fromMentha haplocalyxBriq. Helv Chim Acta. 2010, 93: 2495-2498. 10.1002/hlca.201000143.
Tai T, Shingu T, Kikuchi T, Tezuka Y, Akahori A: Triterpenes from the surface layer ofPoria cocos. Phytochemistry. 1995, 39: 1165-1169. 10.1016/0031-9422(95)00110-S.
Kemami WHV, Berg A, Hertel W, Nkengfack AE, Heartweck C: Anti-inflammatory and anti-hyaluronate lyase activities of lanostanoids fromPiptoporus betulinus. J Antibiot. 2004, 57: 755-758. 10.7164/antibiotics.57.755.
This work was supported by Important National Science & Technology Specific Projects during the 11th Five-Year Plan Period (NO. 2009ZX09502-006), Innovative research team of Beijing University of Chinese Medicine (NO. 2011-CXTD-12), the Twelfth Five-Year National Science & Technology Support Program (NO. 2012BAI29B06), National Natural Science Foundation of China (NO. 81102776) and the Beijing Nova program (NO. 2011070).
The authors declare that they have no competing interests.
GS carried out the chemical analysis-structure elucidation and drafted the Manuscript; NZ carried out the chemical studies; SW employed in the several chemical assays of extraction and isolation; YL worked at the part of experimental design; YB engaged in the part of chemical analysis-structure elucidation; CS carried out the part of chemical assays of extraction and isolation; SR conceived of the study and its design and coordination of the scientific teams. All authors have read and approved the final manuscript.
Gaimei She, Nailiang Zhu contributed equally to this work.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.